🇺🇸 FDA
Pipeline program

autologous decidual-like NK cells

2024-LCYJ-PY-50

Phase 1 mab active

Quick answer

autologous decidual-like NK cells for Abortion, Habitual is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Abortion, Habitual
Phase
Phase 1
Modality
mab
Status
active

Clinical trials